Sun Pharmaceutical
Industries Limited is counted among the best Pharma companies of Bangalore and
listed in the stock market as (NSE: SUNPHARMA, BSE: 524715). It is an Indian
multinational pharmaceutical company that has headquartered in Mumbai,
Maharashtra and has been known for manufacturing quality products at affordable
price. Company manufactures and sells pharmaceutical products and has huge
market share in India and the United States. Company primarily manufactures
drugs for cardiology, psychiatry, neurology, gastroenterology and diabetology.
Sun Pharmaceuticals
was started by Mr. Dilip Shanghvi in the year 1983 in Vapi and has been
manufacturing various products to treat psychiatry ailments. Cardiology
products Company had introduced in 1987 and after 20 years has become the
largest chronic prescription company. In the year 2014 to expend business
company has acquired Ranbaxy and has made the Sun Pharma a largest Indian
pharma company in the US and India.
More than 72% of the
company comes from overseas market and US is the single largest market of the
company and contribute 50% turnover of the company. Company has manufacturing
units at 26 locations that includes production plants in US, Canada, Brazil,
Mexico and Israel. Overall company has excellent team of capable employees that
has deep domain knowledge of their respective field.
Company has very
strong management team that includes
· Israel Makov: Chairman
· Dilip Shanghvi: Managing Director
· Sudhir V. Valia: Executive Director
· Sailesh T. Desai: Executive Director
· Hasmukh S. Shah: Non Executive Independent
Director
· Keki M Mistry: Non Executive Independent
Director
· Ashwin Dani: Non Executive Independent
Director
· S. Mohanchand Dadha: Non Executive Independent
Director
· Rekha Sethi: Non Executive Independent
Director
· Vijay Patel: Non Executive Independent
Director
Below mention is the
essential information about the company :
Type : Public | Traded
as BSE: 524715, NSE: SUNPHARMA | Industry : Pharmaceuticals |
Founded
2001 | Headquarters : Mumbai, Maharashtra, India | Key people : dilip
shangavi (Chairman), Dilip Shanghvi (Managing Director) | Products :
Pharmaceuticals, generic drugs | Revenue
Increase ₹133627 crore (US$20 billion) (2015) | Operating income : Increase
₹36500 crore (US$5.4 billion) (2015) | Net income : Increase : ₹55000
crore (US$8.1 billion) (2015) | Total assets : Increase ₹155000 crore (US$23
billion) (2015) | Number of employees : 32,700 (March 2015)
Information about Pharma Companies in Mumbai - http://companiesinindia.net/pharma/mumbai.html
Nice Blog..Thanks for sharing.
ReplyDeleteWeb Design and Development Bangalore | Web Designing Company In Bangalore | Web Development Company Bangalore |
Web Design Company Bangalore